Back to Journals » Journal of Experimental Pharmacology » Volume 11

Glycine supplementation mitigates lead-induced renal injury in mice

Authors Shafiekhani M, Ommati MM, Azarpira N, Heidari R, Salarian AA

Received 14 October 2018

Accepted for publication 14 January 2019

Published 18 February 2019 Volume 2019:11 Pages 15—22


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Editor who approved publication: Professor Bal Lokeshwar

Mojtaba Shafiekhani,1,2 Mohammad Mehdi Ommati,3 Negar Azarpira,4 Reza Heidari,3 Amir Ahmad Salarian1

1Toxin Research Center, Faculty of Medicine, Aja University of Medical Science, Tehran, Iran; 2Department of Clinical Pharmacy, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran; 3Pharmaceutical Sciences Research Center, Faculty of Pharmacy, Shiraz University of Medical Sciences, Shiraz, Iran; 4Department of Pathology, Transplant Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

Purpose: Lead (Pb) is an environmental pollutant responsible for various organ damages including renal injury. It seems that OS and associated events are crucial mechanisms of lead-induced renal dysfunction. The current study aimed to explore the potential protective effects of glycine against renal injury caused by lead in mice.
Materials and methods: Mature male mice (n=32) were allocated into four groups. The following treatment regimens were the control (vehicle-treated); Pb-acetate (20 mg/kg/day, gavage); Pb-acetate + glycine (500 mg/kg/day, IP); and Pb-acetate + glycine (1,000 mg/kg/day, IP). Pb-acetate + glycine was administered for 14 consecutive days, Pb-acetate was given first and then glycine at least 6 hours later. On day 15, the subjects were anesthetized, and samples were collected. Serum biomarkers such as BUN and serum creatinine were monitored along with formation of reactive oxygen species, lipid peroxidation, kidney GSH level, and histopathological changes.
Results: Based on the results, BUN and serum creatinine levels significantly increased ­following exposure to lead. Glycine supplementation (500 and 1,000 mg/kg, IP) decreased BUN and ­creatinine serum levels (P<0.001). Biomarkers of OS were also reduced in renal tissue ­following glycine therapy in Pb-exposed mice (P<0.001). Histopathological changes were observed in mice treated with lead as tubular dilation, protein cast, vacuolization, and inflammation. In this regard, glycine inhibited histopathological alterations in kidney caused by lead exposure.
Conclusion: It was found that glycine treatment significantly mitigated Pb-induced renal injury most likely through alleviating OS and the associated deleterious outcomes on the kidney tissue.

Keywords: amino acids, glycine, lead, heavy metals, oxidative stress, nephrotoxicity

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]